Full Press Release Details
1 Healthcare Triangle, Inc. (NASDAQ: HCTI) Transforming Healthcare Through EHR, Cloud, and A.I. Driving Growth, Building Value
2 Forward - Looking Statements This presentation contains forward - looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 . These statements are based on current expectations, estimates, forecasts, and projections about the industry and markets in which Healthcare Triangle, Inc . operates, as well as management's beliefs and assumptions . Forward - looking statements include, but are not limited to, statements regarding revenue growth, margin expansion, market opportunities, and strategic initiatives . These statements involve risks, uncertainties, and assumptions that are difficult to predict . Actual outcomes may differ materially from those expressed or implied in any forward - looking statements due to various factors beyond the company's control, including changes in market conditions, client demand, regulatory developments, and execution risks . Readers are cautioned not to place undue reliance on these forward - looking statements . Healthcare Triangle, Inc . undertakes no obligation to publicly update any forward - looking statements, whether as a result of new information, future events, or otherwise, except as required by law .
3 Investment Snapshot - Why HCTI Now "~$20M 2025 Potential with High - Margin Growth Engines 2025 Revenue Outlook & Strategic Positioning Revenue Potential 15.8M committed 2025 backlog + $2M YTD wins = approximately $20M potential 2025 revenue Global Expansion Strategy Expanding globally in EHR, Cloud, and AI verticals Target Gross Margins 30%+ rGM for EHR 40%+ rGM for Cloud 70%+ rGM for AI solutions (10 - 15 pts above industry average) Stable Recurring Base Majority of backlog is multi - year contracts stable recurring revenue base Margin Expansion Drivers Cost optimization and in - house delivery Positioned in High - Growth Markets Three double - digit growth markets: EHR, Cloud, AI EHR 7% CAGR 30%+ rGM Cloud 15% CAGR 40%+ rGM AI 38% CAGR 70%+ rGM Source: Grand View Research, Markets and Markets, Transparent Market Research, Statista, Frost & Sullivan, McKinsey & Company
4 Market Opportunity - "$128 B+ TAM Across Three High - Growth Segments" Market Opportunity EHR (Electronic Health Records) $42B market size 7% CAGR Healthcare Cloud $66B market size 15% CAGR AI in Healthcare $20B market size 38% CAGR Tailwinds Driving Growth Accelerating Digital Transformation Rapid AI Adoption Cost Pressure in Healthcare HCTI Advantage Positioned to capture share in three high growth healthcare tech markets with estimated 30% - 70% target gross margins. Source: Grand View Research, Markets and Markets, Transparent Market Research, Statista, Frost & Sullivan, McKinsey & Company
5 Healthcare Triangle - " Delivering Speed, Savings & Scale in Healthcare Tech" Proven Market Credibility P artnerships: AWS, Google Cloud, Microsoft, Epic, Meditech Compliance: GxP, HIPAA, HITRUST, ISO 27001, PCI Differentiated Technology & Capabilities Fastest Deployments - Up to 70% Cost Savings EHR Expertise - Implementation, cloud hosting, optimization, backup/DR Proprietary Security & Compliance Framework Competitive Advantage for Growth Deep integration across EHR, Cloud, and AI in Healthcare Track record of scaling enterprise clients quickly with high retention 1 2 3
7 Strategic Growth Drivers - "Multi - Lever Growth Engine with Recurring Revenue Potential" Growth Strategy Strategic acquisitions expanding vertical depth - Formation of subsidiary QuantumNexis through the strategic acquisition of Ziloy and Ezovion Global expansion - Management remains focused on expanding the company's geographic reach beyond the U.S. Cross - sell & upsell - Expanding wallet share within the existing client base Recurring SaaS & managed services models - Building predictable, long - term revenue streams Acquisition Expansion Recurring Revenue Acquisition Acquisition : Adds new capabilities and deep domain expertise Expansion : Unlocks new markets and strengthens client engagement Recurring Revenue : SaaS & managed services drives stability and stable cash flow Result : A self - reinforcing cycle that accelerates compounding growth
8 Locked - In Revenue Base + Upside Potential "$20M 2025 Potential: Predictable Base + Momentum QuantumNexis (Subsidiary Company) Signaling $2M revenue upside: Partnership with V - Sure Tech Sdn Bhd Engagement with Malaysia's leading TPA Leadership Strength - Proven Leaders in Fortune 500 & Healthcare Tech - "Proven Leaders in Fortune 500 & Healthcare Tech" Chairman - Dave Rosa : Mr . Dave Rosa has served as a member of Healthcare Triangle's Board of Directors since 2021 . Concurrently, Mr . Rosa serves as President and Chief Executive Officer of NeuroOne Medical Technologies (NMTC), and maintains positions on the boards of other healthcare companies . Prior to joining Healthcare Triangle, Mr . Rosa held senior management roles at several medical device/healthcare technology companies . Mr . Rosa holds a Master of Business Administration degree from Duquesne University, and a Bachelor of Science degree in Commerce and Engineering from Drexel University . COO - Sujatha Ramesh : Ms . Sujatha Ramesh has served as Healthcare Triangle's Chief Operating Officer since March 2025 and is a member of the company's Board of Directors . Prior to joining Healthcare Triangle, Ms . Ramesh held senior executive positions at Citigroup and senior management roles at Publicis Sapient, Infinite Computer Solutions, and Capgemini . She holds a Master of Business Administration (MBA) from the NYU Stern School of Business and a Master of Science in Information Systems and Applications . Ms . Ramesh has been recognized as a Who's Who in America Honored Listee for her contributions to technology, strategic leadership, and enterprise transformation . She has also served as a featured speaker at industry forums, including the Global Financial Market Intelligence event . CFO - David Ayanoglou : Mr . David Ayanoglou has served as Healthcare Triangle's Chief Financial Officer since April 2025 . Prior to joining the company, Mr . Ayanoglou provided corporate finance/financial reporting consulting services to Technology and Healthcare companies, and has held senior management roles at Open Text and KPMG LLP . Mr . Ayanoglou is a Chartered Professional Accountant and Chartered Business Valuator and graduated from the University of Toronto Rotman School of Business . He is corporate finance leader with deep expertise in technology M&A, financial reporting and optimizing capital structures . L ocked - In Revenue Base + Upside Backlog of $15.8M committed with approximately $20M targeted for 2025 New Wins - $2M year - to - date Diversified Revenue Mix - EHR | Cloud | AI
9 Closing - Partnering to Unlock HCTI's Full Potential & Amplify Market Visibility Anchored Revenue Base - Strong, recurring income streams providing stability, predictability and resilience Robust Growth Trajectory - Consistent year - over - year momentum supported by expanding product adoption and market reach. Compelling Market Opportunity - Positioned to capture share in high - growth sectors including EHR, Cloud, and AI. Strategic Goal - Amplify HCTI's growth story - broaden institutional and retail investor awareness - unlock potential for valuation uplift. Growth in Motion